Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P de Moerloose

Showing results (11-20 of 269) with videos related to

Pageof 27
Sort By:
The Analyst|April 1, 1978
Fluorescence properties of metoclopramide and its determination in pharmaceutical dosage formsW Baeyens, P De Moerloose
Annales De Cardiologie Et D'Angeiologie|December 11, 2002
[Diagnosis of deep venous thrombosis of the lower limbs: performance of diagnostic tests]T Merminod, P de Moerloose
Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
Antiphospholipid antibodies: do we still need to perform anticardiolipin ELISA assays?P de Moerloose, G Reber
Annales Francaises D'Anesthesie Et De Reanimation|September 29, 1998
[Preoperative evaluation of hemorrhagic risk]P de Moerloose, O Schneuwly
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1979
[Fluoremetry and various applications in drug analysis]P De Moerloose, W Baeyens
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2016
Can the phenotype of inherited fibrinogen disorders be predicted?A Casini, P de Moerloose
Gynecologie, Obstetrique & Fertilite|October 30, 2001
[Use of anticoagulants during pregnancy]P de Moerloose, F Boehlen
Revue Medicale Suisse|March 19, 2005
[Haemostasis. A search for an ideal antithrombotics agent]P de Moerloose, F Boehlen
Thrombosis and Haemostasis|September 1, 1993
Beta 2-glycoprotein I and antiphospholipid antibodies assays: are we running appropriate sample-blanks?G Reber, P de Moerloose
Die Pharmazie|December 1, 1977
Fluorometric determination of some butyrophenones after permanganate treatmentW Baeyens, P De Moerloose
Pageof 27

Showing results (11-20 of 269) with videos related to

Sort By:
Pageof 27
The Analyst|April 1, 1978
Fluorescence properties of metoclopramide and its determination in pharmaceutical dosage formsW Baeyens, P De Moerloose
Annales De Cardiologie Et D'Angeiologie|December 11, 2002
[Diagnosis of deep venous thrombosis of the lower limbs: performance of diagnostic tests]T Merminod, P de Moerloose
Journal of Thrombosis and Haemostasis : JTH|June 29, 2004
Antiphospholipid antibodies: do we still need to perform anticardiolipin ELISA assays?P de Moerloose, G Reber
Annales Francaises D'Anesthesie Et De Reanimation|September 29, 1998
[Preoperative evaluation of hemorrhagic risk]P de Moerloose, O Schneuwly
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1979
[Fluoremetry and various applications in drug analysis]P De Moerloose, W Baeyens
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2016
Can the phenotype of inherited fibrinogen disorders be predicted?A Casini, P de Moerloose
Gynecologie, Obstetrique & Fertilite|October 30, 2001
[Use of anticoagulants during pregnancy]P de Moerloose, F Boehlen
Revue Medicale Suisse|March 19, 2005
[Haemostasis. A search for an ideal antithrombotics agent]P de Moerloose, F Boehlen
Thrombosis and Haemostasis|September 1, 1993
Beta 2-glycoprotein I and antiphospholipid antibodies assays: are we running appropriate sample-blanks?G Reber, P de Moerloose
Die Pharmazie|December 1, 1977
Fluorometric determination of some butyrophenones after permanganate treatmentW Baeyens, P De Moerloose
Pageof 27